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When death starts with a caspase
 
hen a cytotoxic lymphocyte delivers granzyme B to a 
target cell, current models emphasize that the enzyme 
induces apoptosis through a mitochondria-centered pathway, 
cleaving the proapoptotic Bcl-2 family member Bid to cause 
mitochondrial permeabilization. On page 875, Metkar et al. 
overturn this view, showing that in the dominant pathway 
granzyme B begins by processing procaspase-3, whereas 
mitochondria are secondary components that amplify the signal 
once caspase-3 has been activated. The work adds to recent 
evidence that caspases can initiate apoptosis, whereas mitochondria 
serve as signal amplifiers.
The authors used a 
variety of strategies to 
avoid common pitfalls 
during granzyme-
mediated apoptosis assays. 
In past assays, uncom-
plexed granzyme B was 
added to cell extracts. 
Granzyme B in the new 
assays was delivered into 
cells using adenovirus particles, and was presented in a complex 
with the proteoglycan serglycin to mimic the enzyme’s natural state. 
Doing the apoptosis assays with whole cells minimized the risk of 
proteolysis occurring at sites not normally frequented by granzyme B. 
In this system, Bid cleavage was not detected, and cells deficient 
in procaspase-3 failed to undergo mitochondrial depolarization or 
DNA fragmentation, indicating that granzyme B acts first through 
procaspase-3 rather than the mitochondria. Caspase-3–induced 
permeabilization of the mitochondria amplifies the death signal 
but, based on assays with cells harboring a Bax/Bak deletion, this 
amplification is not essential for apoptosis. 
 
 
W
Granzyme B delivered via adenovirus 
(AD) requires caspase 3 in order 
to kill cells.
 
Fusion failure for ﬂies
 
iu et al. (page 899) genetically disrupted the gene for 
paramyosin, a major component of invertebrate muscle 
thick filaments, in 
 
Drosophila melanogaster
 
. In addition to 
the expected finding, that the disruption damages myofibril 
structure, the work identifies a surprising requirement for 
L
 
paramyosin in myoblast fusion.
Mutant flies in which a 
P-element has been excised 
from the paramyosin promoter 
region die during embryonic 
development. In addition to 
defects in myofibril assembly, 
the embryos exhibit sporadic 
failures in myoblast fusion, 
leading to the absence of 
some muscle fibers. Antibody 
localization experiments show 
paramyosin in discrete foci at 
Normal muscle fiber devel-
opment (top) goes wrong 
without paramyosin (bottom).
 
sites near the junctions of fusing myoblasts, and nonmuscle 
myosin appears to colocalize to the same sites.
The authors propose that, in the fly, paramyosin functions 
as a cytoskeletal protein during early development. In this 
model, paramyosin and nonmuscle myosin form minifilaments 
that interact with the actin cytoskeleton and promote myoblast 
fusion. After myoblast fusion, nonmuscle myosin is then 
replaced by muscle myosin to produce thick filament 
precursors, ultimately leading to the construction of normal 
thick filaments. With or without its myosin partners, para-
myosin could function as intermediate filament proteins do 
in vertebrates, attaching to membrane bound proteins to aid 
in fusion. Since 
 
Drosophila
 
 lacks cytoskeletal intermediate 
filaments, paramyosin may have been borrowed for this 
function during evolution.
 
 
 
 
 
When the channels leak, the muscle is weak
 
atients with heart failure often have 
reduced exercise tolerance that cannot 
be explained solely by their impaired 
blood flow. On page 919, Reiken et al. 
identify the molecular defect that may 
underlie this phenomenon, revealing 
promising therapeutic targets and 
supporting a new model for the patho-
genesis of this widespread disease.
Coupling of excitation and contraction 
in skeletal muscle requires the type 1 
ryanodine receptor (RyR1), a calcium 
channel that forms a complex with several 
regulatory proteins. The authors identified 
a unique site on RyR1 that is phosphory-
P
 
lated by protein kinase A; they then 
generated mutant channels that either 
cannot be phosphorylated or that mimic 
constitutively phosphorylated RyR1. 
Phosphorylation of the channel causes it 
to dissociate from the regulatory protein 
FKBP12, allowing the channel to open 
Phosphorylated ryanodine receptors open 
more often (bottom) and may lead 
to decreased exercise tolerance.
 
more frequently. Compared with RyR1 
in normal skeletal muscle, RyR1 from 
animal models of heart failure is hyper-
phosphorylated, and the rate of calcium 
release and decay of calcium transients are 
both slowed.
Reiken et al. propose that the hyper-
adrenergic state of heart failure causes 
hyperphosphorylation of ryanodine 
receptors in both cardiac and skeletal 
muscle, allowing calcium leakage through 
the channels. The muscles’ effort to 
compensate for the leakage of calcium 
stores may increase energy consumption, 
thus decreasing exercise tolerance. 
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